Search research articles
Contact Us
Filters
Showing results (421-430 of 480) with videos related to
Page
of 48
Sort By:
International Psychogeriatrics
|
August 20, 2025
Recommendations for management and future investigation of psychosis in neurodegenerative disease: Findings from the International Psychogeriatric Association (IPA) working group
Andrew A Namasivayam, Corinne E Fischer, Victor Abler, et al.
The Lancet. Psychiatry
|
June 22, 2020
Multidisciplinary research priorities for the COVID-19 pandemic - Authors' reply
Rory C O'Connor, Matthew Hotopf, Carol M Worthman, et al.
Trials
|
July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol
Caroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
The Lancet. Healthy Longevity
|
December 30, 2024
Assessment and management of frailty in individuals living with dementia: expert recommendations for clinical practice
Miguel Germán Borda, Francesco Landi, Tommy Cederholm, et al.
Journal of Neuroinflammation
|
November 22, 2023
Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge
Oliver Cousins, Julia J Schubert, Avinash Chandra, et al.
International Journal of Geriatric Psychiatry
|
February 23, 2018
A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025
James Pickett, Cathy Bird, Clive Ballard, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
Alistair Burns, John O'Brien, , et al.
Alzheimer'S Research & Therapy
|
November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation
Anne Corbett, Janet Sultana, Kate Stych, et al.
Lancet (London, England)
|
October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
Sube Banerjee, Juliet High, Susan Stirling, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
September 30, 2020
Agitation and impulsivity in mid and late life as possible risk markers for incident dementia
Daniel R Bateman, Sascha Gill, Sophie Hu, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 480) with videos related to
Sort By:
Page
of 48
International Psychogeriatrics
|
August 20, 2025
Recommendations for management and future investigation of psychosis in neurodegenerative disease: Findings from the International Psychogeriatric Association (IPA) working group
Andrew A Namasivayam, Corinne E Fischer, Victor Abler, et al.
The Lancet. Psychiatry
|
June 22, 2020
Multidisciplinary research priorities for the COVID-19 pandemic - Authors' reply
Rory C O'Connor, Matthew Hotopf, Carol M Worthman, et al.
Trials
|
July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol
Caroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
The Lancet. Healthy Longevity
|
December 30, 2024
Assessment and management of frailty in individuals living with dementia: expert recommendations for clinical practice
Miguel Germán Borda, Francesco Landi, Tommy Cederholm, et al.
Journal of Neuroinflammation
|
November 22, 2023
Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge
Oliver Cousins, Julia J Schubert, Avinash Chandra, et al.
International Journal of Geriatric Psychiatry
|
February 23, 2018
A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025
James Pickett, Cathy Bird, Clive Ballard, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
Alistair Burns, John O'Brien, , et al.
Alzheimer'S Research & Therapy
|
November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation
Anne Corbett, Janet Sultana, Kate Stych, et al.
Lancet (London, England)
|
October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
Sube Banerjee, Juliet High, Susan Stirling, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
September 30, 2020
Agitation and impulsivity in mid and late life as possible risk markers for incident dementia
Daniel R Bateman, Sascha Gill, Sophie Hu, et al.
Page
of 48